🩸🩺Today’s questions!

Swipe to see the answers and their explanations!

#Myelofibrosis #MDS #Hematology #MedEd #BloodDisorders #Luspatercept #Imetelstat #Navtemadlin #Pelabresib #Anemia #HEMEHUB

🩸 Additional insights on combination & emerging therapies in Myelofibrosis

#Myelofibrosis #HemeOnc #Hematology #MedEd #ClinicalTrials #HEMEHUB #Luspatercept #PIM1 #Nuvisertib #TP3654 #Ruxolitinib #Momelotinib #Imetelstat #TregTherapy #Immunotherapy

Imetelstat Improves Fatigue and QoL in Transfusion-Dependent Lower-Risk MDS Imetelstat was associated with sustained improvements in fatigue and QOL alongside RBC transfusion independence in MDS.

#Imetelstat Improves Fatigue and QoL in Transfusion-Dependent Lower-Risk #MDS

Benefits in fatigue and #QOL were observed across baseline risk features, including ring sideroblast status. Study in Haematologica

Read more: https://bit.ly/4a6lTGT

#RareDisease #MedSky

Urgent Notice for Geron Corporation Shareholders: Legal Rights Discussion by May 2025 Geron Corporation shareholders are urged to contact The Gross Law Firm before May 12, 2025, to explore their legal rights regarding stock performance and potential claims.

Urgent Notice for Geron Corporation Shareholders: Legal Rights Discussion by May 2025 #United_States #New_York #Gross_Law #Geron_Corporation #imetelstat

2024 approvals: Summary of 12 new 💊indications in heme malignancies by FDA:

1. #Zanubrutinib
2. #Ponatinib
3. #LisoCel x2
4. #Imetelstat
5. #Epcortimab
6. #Daratumuab
7. #Axatilimab
8. #Isatuximab
9. #Asciminib
10. #ObiCel
11. #Revumenib

#HemeSky #OncSky #mmsm #leusm #MedSky #lymsm